J.P. Jacquin

677 total citations
12 papers, 512 citations indexed

About

J.P. Jacquin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, J.P. Jacquin has authored 12 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in J.P. Jacquin's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). J.P. Jacquin is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). J.P. Jacquin collaborates with scholars based in France, Belgium and United States. J.P. Jacquin's co-authors include B. Weber, Gilles Freyer, Éric Pujade-Lauraine, N. Tubiana-Mathieu, G. Ganem, J. Provençal, Sandrine Touzet, J.-F. Geay, O. Gisserot and Yacine Merrouche and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

J.P. Jacquin

12 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.P. Jacquin France	8	215	211	209	106	79	12	512
J. Provençal France	5	148 0.7×	169 0.8×	106 0.5×	77 0.7×	76 1.0×	10	366
J.-F. Geay France	6	176 0.8×	169 0.8×	106 0.5×	84 0.8×	147 1.9×	15	479
Björn Penninckx United Kingdom	5	160 0.7×	146 0.7×	82 0.4×	93 0.9×	72 0.9×	7	378
Regina Gironés Spain	16	313 1.5×	150 0.7×	98 0.5×	273 2.6×	183 2.3×	47	666
Donald Poon Singapore	10	314 1.5×	141 0.7×	120 0.6×	103 1.0×	84 1.1×	14	774
Lorenzo Dottorini Italy	13	330 1.5×	80 0.4×	167 0.8×	143 1.3×	61 0.8×	42	664
Chie Akiba United States	5	223 1.0×	333 1.6×	195 0.9×	131 1.2×	65 0.8×	7	597
Capucine Baldini France	10	184 0.9×	93 0.4×	41 0.2×	96 0.9×	46 0.6×	19	336
J.M. Jonker Netherlands	6	187 0.9×	334 1.6×	236 1.1×	121 1.1×	86 1.1×	6	609
Francesco Savinelli France	6	90 0.4×	79 0.4×	103 0.5×	36 0.3×	50 0.6×	13	259

Countries citing papers authored by J.P. Jacquin

Since Specialization

Citations

This map shows the geographic impact of J.P. Jacquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Jacquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Jacquin more than expected).

Fields of papers citing papers by J.P. Jacquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Jacquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Jacquin. The network helps show where J.P. Jacquin may publish in the future.

Co-authorship network of co-authors of J.P. Jacquin

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Jacquin. A scholar is included among the top collaborators of J.P. Jacquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Jacquin. J.P. Jacquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bachelot, Thomas, Florence Dalenc, Sylvie Chabaud, et al.. (2021). Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer. Annals of Oncology. 32(4). 574–575. 8 indexed citations

Barthélémy, Philippe, J-M Ferrero, J.P. Jacquin, et al.. (2017). Abstract OT1-04-07: VICTORIANE: A randomized phase 3 study assessing the addition of oral vinorelbine to aromatase inhibitors for the treatment of patients with metastatic breast cancer. Cancer Research. 77(4_Supplement). OT1–4. 1 indexed citations

Penault–Llorca, F, Jean‐Christophe Grenier, Marianne Leheurteur, et al.. (2017). Abstract P2-05-10: UCBG 2-14: A prospective multicenter non-randomized trial evaluating the effect of EndoPredict® (EPclin®) clinico-genomic test on treatment decision making among patients with intermediate clinical risk. Cancer Research. 77(4_Supplement). P2–5. 2 indexed citations

Nabholtz, Jean‐Marc, Nasséra Chalabi, Nina Radosevic‐Robin, et al.. (2015). Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer. International Journal of Cancer. 138(9). 2274–2280. 46 indexed citations

Falandry, Claire, Étienne Brain, Marc Bonnefoy, et al.. (2013). Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial. European Journal of Cancer. 49(13). 2806–2814. 28 indexed citations

Pivot, Xavier, Gilles Romieu, Hervé Bonnefoi, et al.. (2012). Phare Trial Results Comparing 6 to 12 Months of Trastuzumab in Adjuvant Early Breast Cancer. Annals of Oncology. 23. ixe2–ixe2. 13 indexed citations

Falandry, Claire, Étienne Brain, Marc Bonnefoy, et al.. (2011). Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial.. Journal of Clinical Oncology. 29(15_suppl). 9122–9122. 6 indexed citations

Ray-Coquard, Isabelle Laure, J. Provençal, Anne‐Claire Hardy‐Bessard, et al.. (2009). Can adjuvant homeopathy improve the control of post-chemotherapy emesis in breast cancer patients? Results of a randomized placebo-controlled trial. Journal of Clinical Oncology. 27(15_suppl). e20566–e20566. 1 indexed citations

Nourissat, Alice, Marie‐Paule Vasson, Yacine Merrouche, et al.. (2008). Relationship between nutritional status and quality of life in patients with cancer. European Journal of Cancer. 44(9). 1238–1242. 98 indexed citations

10.

Nourissat, Alice, J.P. Jacquin, P. Fournel, et al.. (2007). Estimation of the risk for nutritional state degradation in patients with cancer: development of a screening tool based on results from a cross-sectional survey. Annals of Oncology. 18(11). 1882–1886. 23 indexed citations

11.

Freyer, Gilles, J.-F. Geay, Sandrine Touzet, et al.. (2005). Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Annals of Oncology. 16(11). 1795–1800. 251 indexed citations

12.

Guastalla, Jean‐Paul, Éric Pujade-Lauraine, B. Weber, et al.. (1998). Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. Annals of Oncology. 9(1). 37–43. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact